ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial Posted on September 18, 2018 by ARCA IT - Press Release, Uncategorized Gencaro Phase 3 FDA SPA Submission - FINAL
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on August 9, 2018 by ARCA IT - Press Release, Uncategorized ABIO - 2Q18 Financial Results and Business Update - FINAL
ARCA BIOPHARMA ANNOUNCES POSITIVE OUTCOME OF END-OF-PHASE 2 MEETING WITH FDA ON GENCARO DEVELOPMENT FOR ATRIAL FIBRILLATION Posted on July 31, 2018 by ARCA IT - Press Release, Uncategorized End of Phase 2 FDA meeting - FINAL
GENETIC-AF Phase 2B Clinical Trial Results Presented in Late Breaking Presentation at European Society of Cardiology Heart Failure 2018 World Congress Posted on May 29, 2018 by ARCA IT - Press Release, Uncategorized ESC Heart Failure 2018 - GENETIC-AF Data Presentation - FINAL
ARCA biopharma Announces Phase 2B GENETIC-AF Clinical Trial Results Selected for Late Breaking Oral Presentation at European Society of Cardiology Heart Failure 2018 World Congress Posted on May 10, 2018 by ARCA IT - Press Release, Uncategorized ESC Heart Failure 2018 - GENETIC-AF Late Breaker Acceptance - FINAL
ARCA biopharma Announces First Quarter 2018 Financial Results and Provides Corporate Update Posted on May 8, 2018 by ARCA IT - Press Release, Uncategorized ABIO - 1Q18 Financial Results and Business Update - FINAL
ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement Posted on April 23, 2018 by ARCA IT - Press Release, Uncategorized Medtronic Collaboration Agreement Extension - FINAL
ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update Posted on March 22, 2018 by ARCA IT - Press Release, Uncategorized ABIO - 2017 Financial Results and Business Update - FINAL
ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial Posted on February 26, 2018 by ARCA IT - Press Release, Uncategorized GENETIC-AF Topline Data - FINAL
ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial Posted on January 8, 2018 by ARCA IT - Press Release, Uncategorized GENETIC-AF Trial Completion - FINAL